Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New use for ondansetron tested in clinical trials

June 5, 1997

Novel antiparkinsonian agent in development at Kyowa Hakko

June 5, 1997

Merz glycineB antagonists characterized

June 5, 1997

Preclinical and preliminary clinical data on anseculin reported

June 5, 1997

New series for dementia from SIBIA Neurosciences

June 4, 1997

New analgesic under development by BioChem Pharma and Astra

June 4, 1997

Shire & Janssen acquire rights to Nivalin

June 4, 1997

Preclinical and clinical data support use of cerebrocrast as neuroprotectant

June 4, 1997

NeoTherapeutics reports AIT-082 interim phase I/II results

June 3, 1997

Neurobiological Technologies' Xerecept shows antiedema activity

June 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...